Observational analysis revealed Syzygium samarangense extracts lower hyperglycemia and inflammation in diabetic rats, indicating potential as a T2DM therapy.
Key Points
Administration of Syzygium samarangense fruit extract reduced hyperglycemia and improved insulin levels in diabetic rats.
Significant decreases in oxidative stress markers MDA and pro-inflammatory cytokine TNF-α were observed following treatment.
The study utilized a diabetic rat model to assess biochemical changes, evaluating metabolic parameters over four weeks.
Results suggest Syzygium samarangense may support new strategies for managing type 2 diabetes through antioxidant and anti-inflammatory actions.